KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Non-cash Items (2016 - 2025)

Historic Non-cash Items for Encompass Health (EHC) over the last 17 years, with Q3 2025 value amounting to $95.8 million.

  • Encompass Health's Non-cash Items fell 2016.67% to $95.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $386.8 million, marking a year-over-year increase of 690.99%. This contributed to the annual value of $403.4 million for FY2024, which is 734.43% up from last year.
  • According to the latest figures from Q3 2025, Encompass Health's Non-cash Items is $95.8 million, which was down 2016.67% from $84.4 million recorded in Q2 2025.
  • In the past 5 years, Encompass Health's Non-cash Items ranged from a high of $184.8 million in Q2 2022 and a low of -$15.4 million during Q3 2022
  • For the 5-year period, Encompass Health's Non-cash Items averaged around $90.5 million, with its median value being $95.8 million (2025).
  • In the last 5 years, Encompass Health's Non-cash Items crashed by 11086.04% in 2022 and then skyrocketed by 75259.74% in 2023.
  • Over the past 5 years, Encompass Health's Non-cash Items (Quarter) stood at $31.6 million in 2021, then skyrocketed by 68.35% to $53.2 million in 2022, then skyrocketed by 37.97% to $73.4 million in 2023, then skyrocketed by 56.68% to $115.0 million in 2024, then fell by 16.7% to $95.8 million in 2025.
  • Its last three reported values are $95.8 million in Q3 2025, $84.4 million for Q2 2025, and $91.6 million during Q1 2025.